Remedy Robotics Unveils AI-Powered Remote Endovascular Surgery System
Remedy Robotics has introduced the Remedy N1 System, an AI-powered robotic platform designed for remote endovascular surgery, announced in a press release. The system enables clinicians to perform procedures such as stroke or heart attack interventions from any location, using a combination of proprietary robotics and AI-enabled software.
The company reported that the Remedy N1 System successfully completed the world’s first fully remote in-human neurointerventional procedures. These operations were performed between St. Michael’s Hospital and St. Joseph’s Health Centre in Toronto, demonstrating the ability to conduct endovascular treatments across hospital sites.
The N1 System integrates with standard catheterization labs and allows control of up to four surgical tools simultaneously. It includes AI-assisted imaging integration for CT and MRI scans, providing real-time visibility and precision. Clinicians operate the robot through a portable console capable of managing all instruments, fluidics, and audiovisual communication remotely.
Following these initial procedures, Remedy Robotics plans to expand clinical trials and explore additional cardiovascular applications for its system, which remains under development and is not yet commercially available.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Robotics Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Robotics
Nov 13 GXO and Apptronik plan rollout of up to 1,000 Apollo humanoid robots from 2027 Nov 13 TIER IV and Komatsu start building autonomous driving systems for three dump trucks Nov 13 German military grounds Quantum Systems drones after malware hits update server Nov 13 Foundation says it is in talks to supply humanoid robots to Israel's military Nov 12 Eureka Robotics launches StereoPick to let factory teams set up 3D bin picking without codeMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Tairex Launches Multi Agent System for Clinical Collaboration
AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses
RADPAIR builds its AI radiology reporting into Novarad's NovaPACS imaging platform
TCS Showcases Haptic Feedback System for Robotic Surgery
Neura Robotics Launches Neuron AI for Humanoid Robots
Daily AI Brief: the AI news that matters, in your inbox.